Espinosa-Bustos, C.; Leitzbach, L.; Añazco, T.; Silva, M.J.; Campo, A.d.; Castro-Alvarez, A.; Stark, H.; Salas, C.O.
Substituted Purines as High-Affinity Histamine H3 Receptor Ligands. Pharmaceuticals 2022, 15, 573.
https://doi.org/10.3390/ph15050573
AMA Style
Espinosa-Bustos C, Leitzbach L, Añazco T, Silva MJ, Campo Ad, Castro-Alvarez A, Stark H, Salas CO.
Substituted Purines as High-Affinity Histamine H3 Receptor Ligands. Pharmaceuticals. 2022; 15(5):573.
https://doi.org/10.3390/ph15050573
Chicago/Turabian Style
Espinosa-Bustos, Christian, Luisa Leitzbach, Tito Añazco, María J. Silva, Andrea del Campo, Alejandro Castro-Alvarez, Holger Stark, and Cristian O. Salas.
2022. "Substituted Purines as High-Affinity Histamine H3 Receptor Ligands" Pharmaceuticals 15, no. 5: 573.
https://doi.org/10.3390/ph15050573
APA Style
Espinosa-Bustos, C., Leitzbach, L., Añazco, T., Silva, M. J., Campo, A. d., Castro-Alvarez, A., Stark, H., & Salas, C. O.
(2022). Substituted Purines as High-Affinity Histamine H3 Receptor Ligands. Pharmaceuticals, 15(5), 573.
https://doi.org/10.3390/ph15050573